tiprankstipranks
Advertisement
Advertisement

Health In Tech Reports Q1 Loss Amid Revenue Growth

Story Highlights
  • Health In Tech’s Q1 2026 revenue rose 9.4% to $8.8 million but higher growth investments drove a $1.6 million net loss and negative adjusted EBITDA.
  • The company expanded its distribution partners, maintained a strong cash position, reiterated 2026 revenue guidance of $45–$50 million, and emphasized new offerings and rapid feature deployment as growth catalysts in the self-funded health insurance market.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Health In Tech Reports Q1 Loss Amid Revenue Growth

Claim 55% Off TipRanks

The latest update is out from Health In Tech, Inc. Class A ( (HIT) ).

Health In Tech, Inc., an AI-enabled InsurTech platform focused on the U.S. self-funded health insurance market, offers a digital marketplace that automates and simplifies underwriting, sales and servicing for brokers, TPAs, MGUs and carriers. The company enables customized self-funded health plans with stop-loss coverage for employers, leveraging rapid feature deployment and data analytics to differentiate itself from traditional insurance providers.

On May 13, 2026, Health In Tech reported unaudited results for the quarter ended March 31, 2026, showing revenue up 9.4% year over year to $8.8 million, but a swing from profit to a $1.6 million net loss and a negative $1.3 million adjusted EBITDA as it increased sales and marketing investment. The company expanded its distribution network to 896 partners, grew cash and working capital, reiterated its 2026 revenue outlook of $45 million to $50 million supported by $22.9 million of contracted revenue, completed a roughly $7 million private placement in March, and highlighted new product launches and rapid development cycles as key drivers for expected growth in the self-funded stop-loss market in the second half of 2026.

The most recent analyst rating on (HIT) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Health In Tech, Inc. Class A stock, see the HIT Stock Forecast page.

Spark’s Take on HIT Stock

According to Spark, TipRanks’ AI Analyst, HIT is a Neutral.

HIT’s score is driven primarily by solid underlying financial health (very low leverage and improving cash flow) and upbeat 2026 growth guidance from the latest earnings call. These positives are offset by weak technicals (trading below key moving averages with soft momentum) and a high P/E valuation that increases sensitivity to execution and margin consistency.

To see Spark’s full report on HIT stock, click here.

More about Health In Tech, Inc. Class A

Health In Tech, Inc. is an AI-enabled InsurTech platform company that streamlines underwriting, sales and service processes in the health insurance industry through vertical integration, process simplification and automation. Its marketplace connects brokers, third-party administrators, managing general underwriters and carriers with customized self-funded health insurance solutions for employer clients in the U.S. market.

By reducing friction in plan design and placement, the company targets the self-funded health insurance segment, including self-funded plans with stop-loss coverage. Its technology-driven approach aims to accelerate product deployment, enhance data-driven decision-making for ecosystem partners and improve efficiency versus traditional insurance market participants.

Average Trading Volume: 299,644

Technical Sentiment Signal: Strong Sell

Current Market Cap: $86.76M

Learn more about HIT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1